Document Detail


The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trial.
MedLine Citation:
PMID:  21194910     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND AIMS: Low vitamin D levels are associated with increased incidence of future cardiovascular events and are common in stroke patients. We tested whether vitamin D supplementation could reduce blood pressure and improve markers of vascular health in patients who had previously suffered a stroke.
METHODS AND RESULTS: Randomised, placebo-controlled, double-blind trial. Community-dwelling patients with a history of stroke and baseline 25-hydroxyvitamin D levels <75 nmol/L received 100,000 units of oral vitamin D2 or placebo at baseline. Office and 24 h blood pressure, endothelial function measured by flow-mediated dilatation of the brachial artery, cholesterol, oxidised low density lipoprotein, B-type natriuretic peptide and heart rate turbulence were measured at baseline, 8 weeks and 16 weeks. 58 patients were randomised. Mean age was 67 years, mean baseline blood pressure 128/72 mmHg, mean baseline 25-hydroxyvitamin D level was 38 nmol/L. Serum 25-hydroxyvitamin D levels were higher in the intervention group at 8 weeks compared to placebo (54 vs 42 nmol/L, P = 0.002) and remained higher at 16 weeks. Office systolic and diastolic blood pressure showed no significant change between groups at 8 weeks (systolic 126.1 vs 131.3 mmHg; adjusted P = 0.97); (diastolic 73.1 vs 74.9 mmHg, adjusted P = 0.15). Flow mediated dilatation was significantly higher in the intervention group at 8 weeks (6.9% vs 3.7%, adjusted P = 0.007) but was not significantly different at 16 weeks.
CONCLUSIONS: High dose oral vitamin D supplementation did not improve blood pressure but produced short-term improvement in endothelial function in stroke patients with well-controlled baseline blood pressure.
CLINICAL TRIALS REGISTRATION: ISRCTN28737567.
Authors:
M D Witham; F J Dove; J A Sugden; A S Doney; A D Struthers
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial     Date:  2010-12-30
Journal Detail:
Title:  Nutrition, metabolism, and cardiovascular diseases : NMCD     Volume:  22     ISSN:  1590-3729     ISO Abbreviation:  Nutr Metab Cardiovasc Dis     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-09-11     Completed Date:  2013-02-07     Revised Date:  2014-07-31    
Medline Journal Info:
Nlm Unique ID:  9111474     Medline TA:  Nutr Metab Cardiovasc Dis     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  864-70     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier B.V. All rights reserved.
Data Bank Information
Bank Name/Acc. No.:
ISRCTN/ISRCTN28737567
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Biological Markers / blood
Blood Pressure / drug effects
Brachial Artery / drug effects,  physiopathology
Dietary Supplements*
Double-Blind Method
Endothelium / metabolism
Female
Heart Rate
Humans
Lipoproteins, LDL / blood
Male
Middle Aged
Natriuretic Peptide, Brain / blood
Stroke / blood*,  complications,  physiopathology
Vitamin D / administration & dosage*,  blood*
Vitamin D Deficiency / complications,  drug therapy*,  physiopathology
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Lipoproteins, LDL; 0/oxidized low density lipoprotein; 114471-18-0/Natriuretic Peptide, Brain; 1406-16-2/Vitamin D

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disea...
Next Document:  Folate, vitamin B(12) and total homocysteine levels in Arab adolescent subjects: Reference ranges an...